- 1. 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone
- [An azetidinone derivative and a cholesterol absorption inhibitor with lipid-lowering activity. Ezetimibe appears to interact physically with cholesterol transporters at the brush border of the small intestine and inhibits the intestinal absorption of cholesterol and related phytosterols. As a result, ezetimibe causes a decrease in the level of blood cholesterol or an increase in the clearance of cholesterol from the bloodstream. Overall, the following effects observed are a reduction of hepatic cholesterol stores and a reduction of total cholesterol, LDL cholesterol, and other triglycerides in the blood. ( NCI )] (UMLS (NCI) C1142985) EZETIMIBE;
EZETIMIBE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=[CV350] ANTILIPEMIC AGENTS;
Unclassified Ingredients =EZETIMIBE 10 MG;
| - 51. Flathead-Kalispel
- (UMLS (HL7) C1551953) Kalispel;
=Language =InteriorSalish;
|
- 2. 1-fluoro-2,4-dinitrobenzene
- [Irritants and reagents for labeling terminal amino acid groups. ( MSH )] (UMLS (NCI) C0012463) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 52. flatulence
- [Gas or air in the gastrointestinal tract. ( NCI )] (UMLS (CSP) C0016204) =Sign or Symptom ;
=gastrointestinal sign/symptom;
|
- 3. 1-Fluoroethene
- [A synthetic, colorless gas that is insoluble in water and soluble in organic solvents. It is used primarily in the production of polyvinyl fluoride and other fluoropolymers. Vinyl fluoride is extremely flammable and emits highly toxic hydrogen fluoride gas when burned. Vinyl fluoride metabolites form covalent DNA adducts that attribute to inhibition of DNA replication and to mutagenicity consequences. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0078265) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 53. Flatulence/gas pain/belching
- (UMLS (ICPC) C0016205) (Flatulence/gas pain/belching; FLATULENTZIA/METEORISMO/KORROKADA/GASAK(HAIREAK); Flatulens/meteorisme/raeben; Flatulentie/meteorisme/boeren; ILMAVAIVAT/ROYHTAILY; Flatulence/eructation/gaz; Flatulenz/Meteorismus/Aufstossen; gazim, tfixut babeten; flatulencia/szelgorcs/puffadas; Flatulenza/meteorismo/eruttazione; FLATULENS/GASS-SMERTE/"LUFT"/RAP; Flatulencia/dor gases/aerofagia; Flatulencia/dolor gas/aerofagia; FLATULENS/VADERSPANNING/RAPNING) Flatulence/gas pain/belching =Sign or Symptom ;
=Body System, Gastrointestinal; Symptoms and Complaints Component |
- 4. 2'-Fluoro-2',3'-Dideoxyadenosine
- [A fluoro-substituted analog of dideoxyadenosine that inhibits reverse transcriptase, thereby inhibiting telomerase activity and subsequent cell proliferation. ( NCI )] (UMLS (NCI) C0220150) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 54. flatworm
- [phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus; includes three classes, Cestoda, Turbellaria, and Trematoda. ( CSP )] (UMLS (CSP) C0032211) =Invertebrate ;
=Invertebrates;
=Cestoda;
fluke;
|
- 5. 2-Fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene
- (UMLS (NCI) C0767920) =Organic Chemical; Pharmacologic Substance ;
| - 55. flavanoid
- [ ] (UMLS (CSP) C0598439) =Organic Chemical
|
- 6. 2-Fluoro-9-beta-arabinofuranosyladenine
- [nucleoside analog used alone or in combination with other agents to treat various cancers, especially leukemia. ( CSP )] (UMLS (NCI) C0059985) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
[AN000] ANTINEOPLASTICS;
9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate;
adenine nucleoside;
nucleoside analog;
=2-F-ara-AMP;
| - 56. flavanolol
- [ ] (UMLS (CSP) C0598440) =Organic Chemical
|
- 7. 2-Fluoro-alpha-methyl-4-diphenylacetic Acid Sodium Salt
- [The sodium salt form of flurbiprofen, a propionic acid derivative and a member of the phenylalkanoic acid group of non-steroidal antiinflammatory drugs (NSAIDs) with analgesic, antiinflammatory and antipyretic effects. Flurbiprofen non-selectively binds to and inhibits cyclooxygenase (COX). This results in a reduction of arachidonic acid conversion into prostaglandins that are involved in the regulation of pain, inflammation and fever. This NSAID also inhibits carbonic anhydrase, thereby reducing the production of hydrogen and bicarbonate ions. Upon ocular administration, flurbiprofen may reduce bicarbonate ion concentrations leading to a decrease in the production of aqueous humor, thereby lowering intraocular pressure. ( NCI )] (UMLS (NCI) C0304658) =Organic Chemical; Pharmacologic Substance ;
=2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid;
[OP900] OPHTHALMICS, OTHER =FLURBIPROFEN SODIUM 0.03 %;
| - 57. flavanone
- [ ] (UMLS (CSP) C0060425) =Organic Chemical ;
|
- 8. 2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid
- [A derivative of propionic acid, and a phenylalkanoic acid derivative of non-steroidal antiinflammatory drugs (NSAIDs) with analgesic, antiinflammatory and antipyretic effects. Flurbiprofen non-selectively binds to and inhibits cyclooxygenase (COX). This results in a reduction of arachidonic acid conversion into prostaglandins that are involved in the regulation of pain, inflammation and fever. This NSAID also inhibits carbonic anhydrase, thereby reducing the production of hydrogen and bicarbonate ions. Upon ocular administration, flurbiprofen may reduce bicarbonate ion concentrations leading to a decrease in the production of aqueous humor, thereby lowering intraocular pressure. ( NCI )] (UMLS (NCI) C0016377) =Organic Chemical; Pharmacologic Substance ;
=Propionic Acids;
[MS102] NONSALICYLATE NSAIS, ANTIRHEUMATIC =2-Fluoro-alpha-methyl-4-diphenylacetic Acid Sodium Salt;
FLURBIPROFEN 100 MG;
FLURBIPROFEN 50 MG;
| - 58. flavin
- [group of compounds containing the isoalloxazine nucleus; characterized by yellow color and intense green fluorescence in the oxidized form. ( CSP )] (UMLS (CSP) C0016213) =Organic Chemical ;
=oxazine;
pigment =[VT106] RIBOFLAVIN |
- 9. 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4[1H,3H]-quinazolinedione
- [3-(2-(4-(p-fluorobenzoyl)-piperidino) ethyl)-2,4-quinazolinedione. ( CSP )] (UMLS (NCI) C0022616) =Organic Chemical; Pharmacologic Substance =quinazoline;
serotonin inhibitor | - 59. flavin containing monooxygense
- [ ] (UMLS (CSP) C0599066) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 10. 5 fluorodeoxycytidine
- [ ] (UMLS (CSP) C0597703) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =deoxycytidine;
halocarbon compound;
nucleoside analog;
| - 60. flavin mononucleotide
- [riboflavin 5'-phosphate; acts as a coenzyme for a number of oxidative enzymes, including NADH dehydrogenase, serving as an electron carrier by being alternately oxidized (FMN) and reduced (FMNH2). ( CSP )] (UMLS (CSP) C0016388) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Biologically Active Substance =[VT106] RIBOFLAVIN;
ribonucleotide;
cofactor;
=RIBOFLAVIN PHOSPHATE 3.6 MG/ML |
- 11. 5 fluorouridine
- [uridine analogs; 18F-labeled compound. ( CSP )] (UMLS (CSP) C0049192) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =deoxyuridine;
fluoropyrimidine;
halocarbon compound;
nucleoside analog | - 61. flavin nucleoside
- [ ] (UMLS (CSP) C0596575) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
|
- 12. 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione
- [An anticancer drug that belongs to the family of drugs called antimetabolites. ( NCI )] (UMLS (NCI) C0016778) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 62. flavin nucleotide
- [ ] (UMLS (CSP) C0596576) =Nucleic Acid, Nucleoside, or Nucleotide ;
|
- 13. 5-Fluoro-2-Deoxycytidine
- [An antimetabolite consisting of a fluorinated pyrimidine analog with potential antineoplastic activity. As a prodrug, 5-fluoro-2-deoxycytidine is converted intracellularly, by deaminases, to the cytotoxic agent 5-Fluorouracil (5-FU). 5-FU is subsequently metabolized to active metabolites including 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP binds to and inhibits thymidylate synthase, thereby reducing the production of thymidine monophosphate leading to depletion of thymidine triphosphate. This inhibits DNA synthesis and cell division. FUTP competes with uridine triphosphate for incorporation into the RNA strand leading to an inhibition of RNA and protein synthesis. Other fluorouracil metabolites also get incorporated into both DNA and RNA, thereby further hampering cellular growth. ( NCI )] (UMLS (NCI) C0049174) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 63. Flaviviridae
- [family of RNA viruses, many of which cause disease in humans and domestic animals; there are three genera Flavivirus, Pestivirus, and Hepacivirus, as well as several unassigned species. ( CSP )] (UMLS (CSP) C0206510) =Virus =RNA virus;
=dengue virus;
Japanese encephalitis virus;
West Nile virus;
yellow fever virus;
HCV;
GB virus C;
Tick borne encephalitis virus |
- 14. 5-Fluoropyrimidinone
- [A fluoronucleoside that inhibits pyrimidine synthesis, interfering with DNA synthesis. ( NCI )] (UMLS (NCI) C0393034) =Organic Chemical; Pharmacologic Substance ;
| - 64. FLAVO/TAX
- (UMLS (NCI) C0393066) =Therapeutic or Preventive Procedure
|
- 15. 5-Fluorouracil/epi
- [An injectable collagen matrix gel containing the antimetabolite fluorouracil and the symhathicomimetic agent epinephrine with potential antineoplastic activity. After intratumoral injection, fluorouracil is converted into the active metabolite 5-fluoroxyuridine monophosphate that competes with uracil during RNA synthesis whereas another active metabolite 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate inhibits thymidylate synthase, thereby interfering with DNA synthesis. Epinephrine, a potent vasoconstrictor, is added to the gel to enhance penetration of fluorouracil into the tumor tissue and reduce dispersion to the surrounding tissues thereby enhancing the local concentration of fluorouracil and increasing its anti-tumor activity. Intratumoral injection of fluorouracil combined with epinephrine may potentially increase chemotherapeutic efficacy compared to systemic administration and reduce systemic toxicity and side effects. ( NCI )] (UMLS (NCI) C0281426) =Clinical Drug
| - 65. flavobacteria
- [ ] (UMLS (CSP) C1056265) Flavobacterium =Bacterium ;
|
- 16. 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
- (UMLS (NCI) C1176020) Sunitinib =Organic Chemical; Pharmacologic Substance
| - 66. Flavobacteriaceae
- [family of bacteria in the order Sphingobacteriales, class Sphingobacteria; gram-negative rods, mostly saprophytic in terrestrial and aquatic habitats. ( CSP )] (UMLS (CSP) C1014716) =Bacterium =bacteria;
|
- 17. 6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid
- [A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU. (NCI04) ( NCI )] (UMLS (NCI) C0280509) =Organic Chemical; Pharmacologic Substance
| - 67. Flavodic Acid
- (UMLS (NCI) C0060435) =Organic Chemical; Pharmacologic Substance
|
- 18. 9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
- [A synthetic glucocorticoid receptor agonist with metabolic, anti-inflammatory and immunosuppressive activity. Desoximetasone activates specific intracellular receptors, which bind to distinct sites on DNA to modify gene transcription. This results in an induction of the synthesis of anti-inflammatory proteins and suppression of the synthesis of inflammatory mediators. This leads to an overall reduction in chronic inflammation and autoimmune reactions. Desoximetasone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ( NCI )] (UMLS (NCI) C0011707) =Steroid; Pharmacologic Substance; Hormone =(11Beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;
Pregnadienediols;
[DE200] ANTI-INFLAMMATORY, TOPICAL;
=DESOXIMETASONE 0.25 %;
DESOXIMETASONE 0.5 %;
DESOXIMETASONE 0.05 % | - 68. flavodoxin
- [low molecular weight iron-free flavoprotein containing one molecule of flavin mononucleotide and isolated from bacteria grown on an iron-deficient medium; can replace ferredoxin in all the electron-transfer functions in which the latter is known to serve in bacterial cells. ( CSP )] (UMLS (CSP) C0016217) =Amino Acid, Peptide, or Protein; Biologically Active Substance =flavoprotein;
redoxin |
- 19. 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate
- [The acetate salt form of fluorometholone, a synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone acetate exerts its effect by interacting with cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. ( NCI )] (UMLS (NCI) C0724587) Fluorometholone Acetate;
FLUOROMETHOLONE ACETATE PREPARATION =Steroid; Pharmacologic Substance ;
=FLUOROMETHOLONE;
=FLUOROMETHOLONE ACETATE 0.1 %;
| - 69. flavone
- [A group of 4-keto-FLAVONOIDS. ( MSH )] (UMLS (CSP) C0016219) =Organic Chemical ;
=Bioflavonoid;
Chromones;
flavonoid;
=4',5, 7-Trihydroxyisoflavone;
(-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one Hydrochloride;
FLAVOXATE |
- 20. FL
- [A state in the southeastern United States. Its capital isTallahassee. ( NCI )] (UMLS (NCI) C0016253) =Geographic Area
| - 70. Flavonoid
- [group af aromatic oxygen heterocyclic compounds (phenyl benzopyrans) widely distributed in higher plants; some are pigments and others have physiologic properties. ( CSP )] (UMLS (NCI) C0596577) =Organic Chemical ;
=benzopyran;
=flavone;
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one;
|
- 21. Flaccid hemiplegia
- [ ] (UMLS (ICD9CM) C0154693) =Sign or Symptom ;
| - 71. Flavonol
- [A group of 3-hydroxy-4-keto-FLAVONOIDS. ( MSH )] (UMLS (NCI) C0060444) =Organic Chemical; Pharmacologic Substance
|
- 22. Flaccid hemiplegia, affecting dominant side
- [ ] (UMLS (ICD9CM) C0375208) =Sign or Symptom
| - 72. Flavopiridol/Fludarabine/Rituximab
- (UMLS (NCI) C1327940) =Therapeutic or Preventive Procedure; ;
|
- 23. Flaccid hemiplegia, affecting nondominant side
- [ ] (UMLS (ICD9CM) C0375209) =Sign or Symptom
| - 73. Flavopiridol/Fluorouracil/Irinotecan/Leucovorin Calcium
- (UMLS (NCI) C1327736) =Therapeutic or Preventive Procedure
|
- 24. Flaccidity
- (UMLS (NCI) C0026825) =Sign or Symptom
| - 74. Flavopiridol/Fluorouracil/Leucovorin Calcium
- (UMLS (NCI) C1327803) =Therapeutic or Preventive Procedure ;
|
- 25. flagellate
- [subphylum of flagellate protozoa; it contains two classes: Phytomastigophora and Zoomastigophora. ( CSP )] (UMLS (CSP) C0024893) =Invertebrate =protozoa;
=Chlamydomonas;
Dinoflagellate;
Euglena;
Giardia;
Trichomonas;
Trypanosomatina;
| - 75. Flavopiridol/Gemcitabine
- (UMLS (NCI) C0935751) =Therapeutic or Preventive Procedure
|
- 26. flagellin
- [diverse group of proteins found in flagella, including motor proteins (e.g. myosin), fibrous structural proteins (e.g. keratin), adhesion proteins (e.g. fibronectin), and others. ( CSP )] (UMLS (CSP) C0016194) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=bacterial protein;
| - 76. Flavopiridol/Imatinib Mesylate
- (UMLS (NCI) C1327991) =Therapeutic or Preventive Procedure ;
|
- 27. flagellum
- [whiplike motility appendage present on cell surfaces; eukaryote flagella arise from basal bodies, and are composed of nine pairs of microtubules arrayed around a central pair; flagella are common to all mastigophoran protozoa and occur in such specialized cells as spermatozoa; bacterial flagella are thinner and simpler, composed of strands of flagellin; flagella have the same basic structure as cilia but are longer in proportion to the cell bearing them and present in much smaller numbers. ( CSP )] (UMLS (CSP) C0016192) =Cell Component =cell component;
| - 77. Flavopiridol/irinotecan
- (UMLS (NCI) C0935729) =Therapeutic or Preventive Procedure
|
- 28. flagellum antigen
- [ ] (UMLS (CSP) C0596574) =Hazardous or Poisonous Substance ;
=bacterial antigen;
bacterial toxin | - 78. Flavopiridol/Trastuzumab
- (UMLS (NCI) C1134676) =Therapeutic or Preventive Procedure
|
- 29. flagellum motility
- [ ] (UMLS (CSP) C0920524) =Cell Function
| - 79. flavoprotein
- [protein containing a flavin ribonucleotide as a prosthetic group; most are enzymes; many are found in complexes containing metal ions and an iron-sulfur complex or a heme; they catalyze a wide variety of oxidation-reduction reactions. ( CSP )] (UMLS (CSP) C0016223) =Amino Acid, Peptide, or Protein; Biologically Active Substance =gene product;
=flavodoxin |
- 30. Flagyl
- (UMLS (NCI) C0699678) =Organic Chemical; Pharmacologic Substance
| - 80. flavor
- [identifiable or distinctive quality of food or drink perceived with the combined senses of taste and smell; substance used to give food or drink an identifiable or distinctive taste. ( CSP )] (UMLS (CSP) C0596585) =Qualitative Concept ;
=Food Science and Technology;
|
- 31. FLAIL CHEST
- [A complication of multiple rib fractures, rib and sternum fractures, or thoracic surgery. A portion of the chest wall becomes isolated from the thoracic cage and exhibits paradoxical respiration. ( MSH )] (UMLS (ICD9CM) C0016196) =Disease or Syndrome =chest injury;
| - 81. flavor
- [ ] (UMLS (CSP) C0699771) =Organ or Tissue Function ;
|
- 32. flame photometry
- [ ] (UMLS (CSP) C0260132) =Laboratory Procedure ;
=spectrometry;
| - 82. flavor
- [A substance (player) added to a mixture (scoper) to make it taste a certain way. In food the use is obvious, in pharmaceuticals flavors can hide disgusting taste of the active ingredient (important in pediatric treatments). ( HL7V3.0 )] (UMLS (HL7) C0475332) =Substance =Unclassified Ingredients;
Inactive Ingredient Preparations;
inactive ingredient;
=CAFFEINE 200 MG Oral (systemic) tablet;
oxybenzone 0.03 MG/MG / padimate-O 0.07 MG/MG Topical Ointment;
Acetaminophen 33.3 MG/ML / Diphenhydramine 1.67 MG/ML Oral Solution;
AL OH 200MG/MG OH 200MG/SIMETHICONE 25MG/5ML SUSP,ORAL;
AL OH 400MG/MG OH 400MG/SIMETHICONE 30MG/5ML LIQUID;
Aluminum Hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet;
Calcium Carbonate 750 MG Chewable Tablet;
CALCIUM CARBONATE/CALCIUM PHOSPHATE PASTE,DENTAL;
CETYLPYRIDINIUM CL/CHLOROPHYL COPPER COMPLEX (ALC F) MOUTHWASH;
Dextromethorphan 15 MG / Pseudoephedrine 30 MG Chewable Tablet;
Dextromethorphan 15 MG Chewable Tablet;
Eucalyptus oil / Menthol Lozenge;
RICELYTE LIQUID,ORAL;
SUSPENDING VEHICLE (SF) LIQUID,ORAL;
NA FLUORIDE 0.2MG/SD ALCOHOL 38-B 6.65%/ML LIQUID |
- 33. Flanders virus
- [ ] (UMLS (CSP) C0318825) =Virus
| - 83. FLAVOXATE
- [A synthetic parasympatholytic with antimuscarinic, muscle relaxant and urinary antispasmodic properties. Flavoxate binds and inhibits muscarinic receptors, thereby suppressing the micturition reflex and increases urinary bladder capacity by modifying the micturition center in the brain stem. In addition, this agent has been found to inhibit cyclic AMP formation in striatal membranes of the brain through stimulation of pertussis toxin-sensitive G protein-coupled receptors which in turn suppress isovolumetric urinary bladder contraction. ( NCI )] (UMLS (NCI) C0016225) =Organic Chemical; Pharmacologic Substance =flavone;
[GU201] ANTISPASMODICS, URINARY =2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate Hydrochloride |
- 34. Flandreau Santee Sioux Tribe of South Dakota
- (UMLS (HL7) C1554302) =Population Group =NativeEntityContiguous;
| - 84. Flaxseed
- [Seed isolated from one of several species of the plant genus Linum. Flaxseed-derived foods, lignans, and essential fatty acids such as alpha-linolenic acid, possess anti-inflammatory, lipid-lowering, antioxidant, and antineoplastic properties. ( NCI )] (UMLS (NCI) C0995001) Flaxseed extract;
FLAXSEED PREPARATION;
Flour, Flaxseed;
Linseed;
LINSEED PREPARATION =Organic Chemical; Pharmacologic Substance =Unclassified Ingredients;
Unclassified Ingredient Preparations =FLAXSEED MEAL;
FLAXSEED WHOLE;
FLAXSEED MEAL;
FLAXSEED WHOLE |
- 35. Flank Mass
- (UMLS (NCI) C0744049) =Disease or Syndrome
| - 85. flea
- [fleas are small and wingless; usually are ectoparasites on birds or mammals; adults feed on the blood of the host and lay eggs in the host or the dirt of the host nest. ( CSP )] (UMLS (CSP) C0016228) =Invertebrate ;
=Insecta;
|
- 36. Flank Pain
- [Pain emanating from below the RIBS and above the ILIUM. ( MSH )] (UMLS (NCI) C0016199) =Sign or Symptom =pain;
| - 86. FLECAINIDE
- [A synthetic agent derived from trifluoroethoxy-benzamide exhibiting antiarrhythmic and local anesthetic activity. As a class Ic antiarrhythmic that blocks sodium channels, flecainide depresses polarization phase 0 and decreases the induction velocity of the His-Purkinje system. It also decreases phase 4 slope and increases the depolarization threshold. (NCI04) ( NCI )] (UMLS (NCI) C0016229) =Organic Chemical; Pharmacologic Substance =[CV300] ANTIARRHYTHMICS;
Piperidines =FLECAINIDE ACETATE |
- 37. Flank symptoms/complaints
- (UMLS (ICPC) C0497259) (Flank symptoms/complaints; S./K. ALDAMENEKOA; Sympt/klage fra flanke; Flank symptomen/klachten; KYLJEN OIREET/VAIVAT; Sympt plaintes flanc; Symptome/Beschwerden Flanke; tlunot o simpt'- moten; lapocka tunet/panasz; Sintomi/disturbi fianco; FLANKE/"SIDEN" SYMPT/PLAGER; Sinais/sintomas do flanco; S/s de los flancos; SYMPTOM/KLAGOMAL BETR FLANK) =Sign or Symptom =musculoskeletal; Symptoms and Complaints Component
| - 87. Fleet
- (UMLS (NCI) C0591516) =Organic Chemical; Pharmacologic Substance
|
- 38. FLAP Regimen
- [A regimen consisting of leucovorin-enhanced fluorouracil, doxorubicin and cisplatin used for the treatment of advanced-stage gastric cancer. ( NCI )] (UMLS (NCI) C0389832) =Therapeutic or Preventive Procedure ;
| - 88. FLEROBUTEROL
- [A beta-adrenoceptor agonist with potential antidepressant activity. Even though preferentially interacts with beta-adrenergic receptors, flerobuterol may exhibit antidepressant activity. Sustained administration of flerobuterol, similar to other beta-adrenergic agonists, may increase serotonin (5-HT) synthesis, thereby enhance serotonergic neurotransmission, partially through an increased transport of the serotonin precursor (tryptophan) to brain. ( NCI )] (UMLS (NCI) C0117861) =Organic Chemical; Pharmacologic Substance ;
|
- 39. flash photolysis
- [technique in which an intense flash of light is used to activate gas molecules so that they can be observed spectroscopically. ( CSP )] (UMLS (CSP) C0260131) =Human-caused Phenomenon or Process ;
=photolysis;
| - 89. flesh fly
- [ ] (UMLS (CSP) C0322494) =Invertebrate
|
- 40. Flashes, hot
- [A sudden, temporary onset of body warmth, flushing, and sweating (often associated with menopause). ( NCI )] (UMLS (NCI) C0600142) =Sign or Symptom ;
=Clinical Finding;
| - 90. Fleurette Formation
- (UMLS (NCI) C1333622) =Finding
|
- 41. flasks
- [ ] (UMLS (CSP) C0872171) =Medical Device ;
| - 91. Flexible Fiberoptic Sigmoidoscopy
- [Examination of the luminal surface of the sigmoid colon, using a flexible fiberoptic endoscope. ( NCI )] (UMLS (NCI) C0016234) =Diagnostic Procedure ;
|
- 42. Flat Adenoma
- [An adenoma of the gastrointestinal tract mucosa which grossly and morphologically does not appear as an elevated or polypoid lesion. ( NCI )] (UMLS (NCI) C1266024) =Neoplastic Process
| - 92. Flexner-Wintersteiner Rosette Formation
- (UMLS (NCI) C1333623) =Finding
|
- 43. Flat Adenoma Syndrome
- (UMLS (NCI) C1333619) =Disease or Syndrome
| - 93. Flexor Carpi Radialis
- (UMLS (NCI) C0224252) =Body Part, Organ, or Organ Component
|
- 44. FLAT ANTERIOR CHAMBER
- (UMLS (ICD9CM) C0271004) =Anatomical Abnormality ;
| - 94. Flexor Carpi Ulnaris
- (UMLS (NCI) C0224254) =Body Part, Organ, or Organ Component
|
- 45. Flat Bone
- (UMLS (NCI) C0222649) =Body Part, Organ, or Organ Component
| - 95. Flexor Digitorum Longus
- (UMLS (NCI) C1261048) =Body Part, Organ, or Organ Component
|
- 46. FLAT FOOT
- (UMLS (ICD9CM) C0264133) =Acquired Abnormality
| - 96. Flexor Digitorum Profundus
- (UMLS (NCI) C0224261) =Body Part, Organ, or Organ Component
|
- 47. FLAT RETINOSCHISIS
- [ ] (UMLS (ICD9CM) C0154817) =Disease or Syndrome ;
| - 97. Flexor Hallucis Longus
- (UMLS (NCI) C0224473) =Body Part, Organ, or Organ Component
|
- 48. Flat Urothelial Hyperplasia
- [A type of hyperplasia that is characterized by a marked thickening of the urinary tract epithelium. There is no evidence of cytologic atypia. — 2003 ( NCI )] (UMLS (NCI) C1333621) =Pathologic Function
| - 98. Flezelastine
- (UMLS (NCI) C0258805) =Organic Chemical; Pharmacologic Substance
|
- 49. Flat-Coated Retriever
- [The Flat-Coated Retriever is a black or liver-colored retriever with a sleek, medium-length, thick coat with well-feathered legs, tail and chest. The moderately small ears lay flat against the head. The chest is deep and wide. Height: 22-23 inches (56-58 cm.) Weight: 60-70 pounds (27-32 kg.) ( NCI )] (UMLS (NCI) C0324429) =Mammal
| - 99. FLI1
- [This gene plays a role in transcriptional activation and has been implicated in the pathogenesis of neuroepithelioma. ( NCI )] (UMLS (NCI) C0808900) FLI1 Gene;
Friend Leukemia Virus Integration 1 Gene =Gene or Genome ;
|
- 50. Flat-rate. Apply the entire price to this interval, do not pro-rate the price if the full interval has not occurred/been consumed
- (UMLS (HL7) C1548512) =Idea or Concept ;
=CP range type;
| - 100. flicker fusion test
- [test in which subjects are required to discriminate flicker from fusion, and vice versa, in a set of light emitting diodes; measures the point or frequency at which the perception of all flicker of an intermittent light stimulus disappears. ( CSP )] (UMLS (CSP) C1313900) =Diagnostic Procedure; ;
=vision test;
|
home
